Showing results (91-100 of 1,252) with videos related to

Sort By:
Pageof 126
Science (New York, N.Y.)|November 22, 1991
Recombinant toxins for cancer treatmentI Pastan, D FitzGerald
Seminars in Cell Biology|February 1, 1991
Redirecting Pseudomonas exotoxinD FitzGerald, I Pastan
The Journal of Biological Chemistry|September 15, 1989
Pseudomonas exotoxin: chimeric toxinsI Pastan, D FitzGerald
Journal of the National Cancer Institute|October 4, 1989
Targeted toxin therapy for the treatment of cancerD FitzGerald, I Pastan
Nature Reviews. Rheumatology|December 15, 2020
Immunogenicity of biologic agents in rheumatologyVibeke Strand, Joao Goncalves, John D Isaacs
Australian and New Zealand Journal of Public Health|November 2, 2001
Cost-effectiveness analysis of changing from live oral poliovirus vaccine to inactivated poliovirus vaccine in AustraliaA W Tucker, D Isaacs, M Burgess
Nature Reviews. Rheumatology|December 11, 2020
Why remission is not enough: underlying disease mechanisms in RA that prevent cureGeorg Schett, Yoshiya Tanaka, John D Isaacs
International Journal of Psychiatry in Clinical Practice|June 14, 2014
Neuroleptic malignant syndrome: Possible induction by olanzapine in a case with relapsing catatoniaJ Segal Michael D Isaacs Michael Berk
The Lancet. Rheumatology|January 30, 2024
The interferon gene signature as a clinically relevant biomarker in autoimmune rheumatic diseaseFaye A H Cooles, John D Isaacs
International Journal of Geriatric Psychiatry|July 2, 2026
England's Dementia Diagnosis Landscape: Strengths, Limitations, and Future DirectionsJemma Hazan, Robert Howard, Jeremy D Isaacs
Pageof 126